BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 277806)

  • 1. The value of clofibrate.
    Hart A
    N Z Med J; 1978 Jun; 87(613):406. PubMed ID: 277806
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clofibrate and ischemic heart disease].
    Oye I
    Tidsskr Nor Laegeforen; 1973 Jan; 93(1):33-4. PubMed ID: 4691223
    [No Abstract]   [Full Text] [Related]  

  • 3. Clofibrate in the management of hyperlipidaemia.
    Drug Ther Bull; 1982 May; 20(11):41-3. PubMed ID: 7140522
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of clofibrate. The opinion of Prof. D. Kritchevsky].
    Fabbrocini V
    Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clofibrate--helpful or harmful?].
    Hartmann G; Micheli H; Mordasini R; Noseda G; Stähelin HB
    Schweiz Med Wochenschr; 1979 Aug; 109(31):1137-9. PubMed ID: 472701
    [No Abstract]   [Full Text] [Related]  

  • 6. [The study of clofibrate. The viewpoint of Professor D. Kritchevsky interviewed by V. Fabbrocini].
    Kritchevsky D
    Minerva Med; 1979 Dec; 70(55):3808-9. PubMed ID: 523009
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clofibrate--overreaction?].
    Viikinkoski P
    Duodecim; 1979; 95(14-15):875-7. PubMed ID: 487961
    [No Abstract]   [Full Text] [Related]  

  • 8. Clofibrate.
    Lancet; 1978 Dec; 2(8103):1302-3. PubMed ID: 82797
    [No Abstract]   [Full Text] [Related]  

  • 9. Clofibrate.
    Downie CC
    Lancet; 1979 Feb; 1(8111):318. PubMed ID: 84964
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypolipidemic efficacy of clofibrate preparations (atromid C, atromidine, mixleron) in coronary atherosclerosis with different types of hyperlipoproteinemia].
    Zakharov VN
    Ter Arkh; 1977; 49(4):111-3. PubMed ID: 867253
    [No Abstract]   [Full Text] [Related]  

  • 11. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug prevention of coronary disease].
    Miettinen TA
    Duodecim; 1972; 88(21):1346-54. PubMed ID: 4570871
    [No Abstract]   [Full Text] [Related]  

  • 13. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):66-71. PubMed ID: 768950
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of hyperlipidemia.
    Margolis S
    Md State Med J; 1970 Nov; 19(11):101-3. PubMed ID: 5523343
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypolipaemic drugs and coronary heart disease.
    Howard AN
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():106-14. PubMed ID: 783209
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperlipidemia: reducing the chances of cardiovascular disease.
    Nash DT
    Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperlipidemia: to treat or not to treat.
    Parsons WB
    Ariz Med; 1975 Apr; 32(4):323-8. PubMed ID: 1119953
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of drugs affecting lipids on atherosclerosis.
    Ditschuneit H
    Horm Metab Res; 1974; Suppl 4():191-4. PubMed ID: 4421312
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of hyperlipidemia in patients with ischemic heart disease].
    Haviar V; Kusá O; Riecanský I; Luknárová O
    Vnitr Lek; 1972 Jun; 18(6):586-91. PubMed ID: 5044447
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-hyperlipemic therapy in the secondary prevention of coronary heart disease. Long-term study].
    Caruzzo C
    Boll Soc Ital Cardiol; 1974; 19(6):503-15. PubMed ID: 4282709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.